reviewTop 1% cited
Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis
British Journal of Ophthalmology · 2019 · Vol. 104(8) · pp. 1077–1084
Jeany Q. Li(University of Bonn)Thomas Welchowski(University of Bonn)Matthias Schmid(University of Bonn)Matthias M. Mauschitz(University of Bonn)Frank G. Holz(University of Bonn)Robert P. Finger✉(University of Bonn)
Abstract
Approximately 67 million people in the EU are currently affected by any AMD and, due to population ageing, this number is expected to increase by 15% until 2050. Monitoring and treatment of people with advanced disease stages will require additional healthcare resources and thorough healthcare planning in the years and decades to come.
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic ConditionsMedicineMacular degenerationIncidence (geometry)Meta-analysisEpidemiologyPopulationDemographyObservational studyGuidelineEnvironmental health
MeSH terms
AgedAged, 80 and overBlindnessEuropeEuropean UnionFemaleHumansMacular DegenerationMacular DegenerationMaleMiddle AgedVisual AcuityVision, LowIncidencePrevalence
Funding
- Else Kröner-Fresenius-Stiftung
Citations
353
FWCI
27.92
field-weighted impact
References
51
Percentile
100%
vs. same field & year
Citations per year
References
Clinical Classification of Age-related Macular Degeneration
Ophthalmology · 2013 · 1,762 citations
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
JAMA · 2000 · 20,480 citations
Quantifying heterogeneity in a meta‐analysis
Statistics in Medicine · 2002 · 36,106 citations
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Ophthalmology · 1995 · 819 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.